Home/Filings/4/0000899243-20-007277
4//SEC Filing

Panzara Michael A. 4

Accession 0000899243-20-007277

CIK 0001631574other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 8:40 PM ET

Size

5.6 KB

Accession

0000899243-20-007277

Insider Transaction Report

Form 4
Period: 2020-03-03
Panzara Michael A.
Franchise Lead, Neurology
Transactions
  • Award

    Share Option (right to buy)

    2020-03-03+36,00036,000 total
    Exercise: $8.17Exp: 2030-03-03Ordinary Shares (36,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 50% of the shares on February 1, 2021 and 50% on February 1, 2022

Issuer

Wave Life Sciences Ltd.

CIK 0001631574

Entity typeother

Related Parties

1
  • filerCIK 0001679039

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 8:40 PM ET
Size
5.6 KB